Shelton Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Sell
1,744
-126
-7% -$17.6K ﹤0.01% 671
2025
Q4
$306K Hold
1,870
0.01% 489
2025
Q3
$250K Hold
1,870
0.01% 575
2025
Q2
$233K Hold
1,870
0.01% 604
2025
Q1
$238K Sell
1,870
-169
-8% -$26K 0.01% 582
2024
Q4
$293K Hold
2,039
0.01% 514
2024
Q3
$303K Sell
2,039
-76
-4% -$10.9K 0.01% 496
2024
Q2
$267K Sell
2,115
-78
-4% -$12.2K 0.01% 543
2024
Q1
$403K Sell
2,193
-61
-3% -$11.6K 0.01% 411
2023
Q4
$405K Sell
2,254
-159
-7% -$24.8K 0.01% 383
2023
Q3
$384K Sell
2,413
-132
-5% -$21.6K 0.01% 368
2023
Q2
$360K Sell
2,545
-97
-4% -$15.6K 0.01% 412
2023
Q1
$445K Hold
2,642
0.02% 327
2022
Q4
$447K Sell
2,642
-88
-3% -$16K 0.05% 290
2022
Q3
$511K Hold
2,730
0.02% 305
2022
Q2
$443K Hold
2,730
0.02% 344
2022
Q1
$513K Hold
2,730
0.02% 355
2021
Q4
$723K Hold
2,730
0.03% 306
2021
Q3
$789K Hold
2,730
0.03% 293
2021
Q2
$545K Hold
2,730
0.02% 357
2021
Q1
$531K Hold
2,730
0.02% 367
2020
Q4
$523K Hold
2,730
0.02% 337
2020
Q3
$403K Hold
2,730
0.02% 467
2020
Q2
$337K Sell
2,730
-214
-7% -$25.2K 0.02% 411
2020
Q1
$284K Hold
2,944
0.02% 410
2019
Q4
$272K Sell
2,944
-1,005
-25% -$84.4K 0.02% 580
2019
Q3
$303K Hold
3,949
0.02% 527
2019
Q2
$339K Buy
3,949
+3,716
+1,595% +$253K 0.02% 475
2019
Q1
$3.95K Sell
233
-3,716
-94% -$214K 0.02% 638
2018
Q4
$208K Buy
3,949
+179
+5% +$10.5K 0.01% 685
2018
Q3
$209K Buy
+3,770
New +$194K 0.01% 834

Other funds holding RGEN

Shelton Capital Management's RGEN Position: Q1 2026 in Review

Shelton Capital Management reduced its Repligen (RGEN) stake by 6.7% in Q1 2026, selling an estimated $17.6K and leaving 1,744 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Shelton Capital Management first reported a position in RGEN in Q3 2018 and has held it in 31 quarters since. The position peaked at $789K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Shelton Capital Management held 1,744 shares of Repligen worth $205K as of Q1 2026.
  • Shelton Capital Management sold 126 Repligen shares in Q1 2026, an estimated $17.6K.
  • Repligen made up ﹤0.01% of Shelton Capital Management's portfolio in Q1 2026, its #671 holding.
  • Shelton Capital Management first reported a position in Repligen in Q3 2018 and has held it in 31 quarters since.
  • Shelton Capital Management's Repligen position peaked at $789K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.